KeyBanc on ICU Medical (ICUI): 'Survey suggests potential market share gains for ICUI'

December 4, 2024 7:12 AM EST Send to a Friend
KeyBanc analyst Brett Fishbin reiterated an Overweight rating and $209.00 price target on ICU Medical (NASDAQ: ICUI) following the infusion ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login